Overview of polymyxin resistance in Enterobacteriaceae
Open Access
- 1 January 2022
- journal article
- review article
- Published by FapUNIFESP (SciELO) in Revista da Sociedade Brasileira de Medicina Tropical
- Vol. 55, e0349
Abstract
Polymyxin antibiotics are disfavored owing to their potential clinical toxicity, especially nephrotoxicity. However, the dry antibiotic development pipeline, together with the increasing global prevalence of infections caused by multidrug-resistant (MDR) gram-negative bacteria, have renewed clinical interest in these polypeptide antibiotics. This review highlights the current information regarding the mechanisms of resistance to polymyxins and their molecular epidemiology. Knowledge of the resistance mechanisms and epidemiology of these pathogens is critical for the development of novel antibacterial agents and rapid treatment choices.Keywords
This publication has 47 references indexed in Scilit:
- Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological studyThe Lancet Infectious Diseases, 2016
- Activity and Predicted Nephrotoxicity of Synthetic Antibiotics Based on Polymyxin BJournal of Medicinal Chemistry, 2016
- Heteroresistance to Colistin in Klebsiella pneumoniae Associated with Alterations in the PhoPQ Regulatory SystemAntimicrobial Agents and Chemotherapy, 2015
- Colistin, mechanisms and prevalence of resistanceCurrent Medical Research and Opinion, 2015
- Colistin for lung infection: an updateJournal of Intensive Care, 2015
- Antibacterial Mechanisms of Polymyxin and Bacterial ResistanceBioMed Research International, 2015
- Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteriaFrontiers in Microbiology, 2014
- Pharmacology of Polymyxins: New Insights into an ‘Old‘ Class of AntibioticsFuture Microbiology, 2013
- PhoQ Mutations Promote Lipid A Modification and Polymyxin Resistance of Pseudomonas aeruginosa Found in Colistin-Treated Cystic Fibrosis PatientsAntimicrobial Agents and Chemotherapy, 2011
- Emerging Severe and Fatal Infections Due to Klebsiella pneumoniae in Two University Hospitals in FranceJournal of Clinical Microbiology, 2011